Intravenous delivery of adipose-derived mesenchymal stromal cells attenuates acute radiation-induced lung injury in rats

Cytotherapy

Volumn 17, Issue 5, 2015, Pages 560-570

  Jiang, Xinping ^a   Jiang, Xin ^a   Qu, Chao ^a   Chang, Pengyu ^a   Zhang, Chu ^c   Qu, Yaqin ^a   Liu, Yongjun ^b  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b Alliancells Bioscience Co Ltd   (China)

^c THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Adipose tissue; Cell based transplantation; Mesenchymal stromal cells; Radiation induced lung injury

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CASPASE 3; COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; PROTEIN BAX; PROTEIN BCL 2; SCATTER FACTOR; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE;

ADIPOSE DERIVED MESENCHYMAL STROMA CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BLOOD LEVEL; CELL PROTECTION; CELL TRANSPLANTATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HISTOPATHOLOGY; LUNG ALVEOLUS CELL; LUNG INJURY; LUNG PARENCHYMA; MESENCHYMAL STROMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; RADIATION INDUCED LUNG INJURY; RAT; TREATMENT OUTCOME; ADIPOSE TISSUE; ANIMAL; BLOOD; CELL CULTURE; CHEMOTAXIS; CYTOLOGY; FIBROSIS; INTRAVENOUS DRUG ADMINISTRATION; LUNG; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PATHOLOGY; RADIATION INJURIES; RADIATION RESPONSE; SPRAGUE DAWLEY RAT; THORAX;

RATTUS;

ADIPOSE TISSUE; ANIMALS; APOPTOSIS; CASPASE 3; CELLS, CULTURED; CHEMOTAXIS; CYTOKINES; FEMALE; FIBROSIS; HEPATOCYTE GROWTH FACTOR; INFLAMMATION MEDIATORS; INJECTIONS, INTRAVENOUS; LUNG; LUNG INJURY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RADIATION INJURIES; RATS, SPRAGUE-DAWLEY; THORAX;

EID: 84933671718     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2015.02.011     Document Type: Article

References (36)

1. Tsoutsou P., Koukourakis M. Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys 2006, 66:1281-1293.
2. Graves P.R., Siddiqui F., Anscher M.S., Movsas B. Radiation pulmonary toxicity: from mechanisms to management. Semin Radiat Oncol 2010, 20:201-207.
3. Abratt R.P., Morga G.W. Lung toxicity following chest irradiation in patients with lung cancer. Lung Cancer 2002, 35:103-109.
4. Roach M., Gandara D.R., Yuo H.S., Swift P.S., Kroll S., Shrieve D.C., et al. Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. JClin Oncol 1995, 13:2606-2612.
5. Cappuccini F., Eldh T., Bruder D., Gereke M., Jastrow H., Schulze-Osthoff K., et al. New insights into the molecular pathology of radiation-induced pneumopathy. Radiother Oncol 2011, 101:86-92.
6. Yufang S., Gangzheng H., Juanjuan S., Wenzhao L., Qing C., Peishun S., et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Research 2010, 20:510-518.
7. Prockop D.J., Oh J.Y. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Therapy 2012, 20:14-20.
8. Blanc K.L., Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol 2012, 12:383-396.
9. Ortiz L.A., Gambelli F., McBride C., Gaupp D., Baddoo M., Kaminski N., et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 2003, 100:8407-8411.
10. Rojas M., Xu J., Woods C.R., Mora A.L., Spears W., Roman J., et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005, 33:145-152.
11. Usunier B., Benderitter M., Tamarat R., Chape A. Management of fibrosis: the mesenchymal stromal cells breakthrough. Stem Cells Int 2014, 2014:340257.
12. Yanxia Z., Tianqing Z., Kedong S., Xiubo F., Xuehu M., Zhanfeng C. Adipose-derived stem cell: A better stem cell than BMSC. Cell Research 2008, 18:S165.
13. Lee R.H., Kim B., Choi I., Kim H., Choi H.S., Suh K., et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004, 14:311-324.
14. Schäffler A., Büchler C. Concise review: adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells 2007, 25:818-827.
15. Morizono K., De Ugarte D.A., Zhu M., Zuk P., Elbarbary A., Ashjian P., et al. Multilineage cells from adipose tissue as gene delivery vehicles. Hum Gene Therapy 2003, 14:59-66.
16. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7:211-228.
17. Rodriguez A.M., Elabd C., Delteil F., Astier J., Vernochet C., Saint-Marc P., et al. Adipocyte differentiation of multipotent cells established from human adipose tissue. Biochem Biophys Res Commun 2004, 315:255-263.
18. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
19. Hua W., Yue-Feng Y., Li Z., Feng-Jun X., Qun-Wei Z., Ming-Ling W., et al. Hepatocyte Growth factor gene-modified mesenchymal stem cells reduce radiation-induced lung injury. Human Gene Ther 2013, 24:343-353.
20. Ji J.F., He B.P., Dheen S.T., Tay S.S. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 2004, 2:415-427.
21. Karvonen R.L., Fernandez-Madrid F., Maughan R.L., Palmer K.C., Fernandez-Madrid I. An animal model of pulmonary radiation fibrosis with biochemical, physiologic, immunologic, and morphologic observations. Radiat Res 1987, 111:68-80.
22. Haston C.K., Travis E.L. Murine susceptibility to radiation -induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis. Cancer Research 1997, 57:5286-5291.
23. Lee R.H., Pulin A.A., Seo M.J., Kota D.J., Ylostalo J., Larson B.L., et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009, 5:54-63.
24. Johnson L.B., Riaz A.A., Adawi D., Wittgren L., Back S., Thornberg C., et al. Radiation enteropathy and leucocyte-endothelial cell reactions in a refined small bowel model. BMC Surg 2004, 4:10.
25. Ortiz L.A., Dutrei M., Fattman C., Pandey A.C., Torres G., Go K., et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A 2007, 104:11002-11007.
26. Li H.D., Zhang Q.X., Mao Z., Xu X.J., Li N.Y., Zhang H. Exogenous interleukin-10 attenuates hyperoxia-induced acute lung injury in mice. Exp Physiol 2015, 100:331-340.
27. Yagi H., Soto-Gutierrez A., Parekkadan B., Kitagawa Y., Tompkins R.G., Kobayashi N., et al. Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant 2010, 19:667-679.
28. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
29. Moodley Y., Atienza D., Manuelpillai U., Samuel C.S., Tchongue J., Ilancheran S., et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin induced lung injury. Am J Pathol 2009, 175:303-313.
30. Rube C.E., Uthe D., Schmid K.W., Richter K.D., Wessel J., Schuck A., et al. Dose-dependent induction of transforming growth factor(TGF-β1) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int J Radiation Oncology Biol Phys 2000, 47:1033-1042.
31. Border W.A., Noble N.A. Transforming growth factor beta in tissue fibrosis. NEng J Med 1994, 331:1286-1292.
32. Gazdhar A., Grad I., Tamò L., Gugger M., Feki A., Geiser T. The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor. Stem Cell Res Ther 2014, 5:123.
33. Marchand Adam S., Fabre A., Mailleux A.A., Marchal J., Quesnel C., Kataoka H., et al. Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006, 174:58-66.
34. Matsumoto K., Nakamura T. Hepatocyte growth factor: Molecular structure, roles in liver regeneration, and other biological functions. Crit Rev Oncog 1992, 3:27-54.
35. Wang X., Zhou Y., Kim H.P., Song R., Zarnegar R., Ryter S.W., et al. Hepatocyte growth factor protects against hypoxia/reoxygenation-induced apoptosis in endothelial cells. JBiol Chem 2004, 279:5237-5243.
36. Shukla M.N., Rose J.L., Ray R., Lathrop K.L., Ray A., Ray P. Hepatocyte Growth Factor Inhibits Epithelial to Myofibroblast Transition in Lung Cells via Smad7. Am J Respir Cell Mol Biol 2009, 40:643-653.